HUP0300504A3 - 19-nor-17alpha-pregna-1,3,5(10)-trien-17betha-ols of a 21,16alpha-lactone ring, process for their preparation and pharmaceutical compositions containing them - Google Patents
19-nor-17alpha-pregna-1,3,5(10)-trien-17betha-ols of a 21,16alpha-lactone ring, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HUP0300504A3 HUP0300504A3 HU0300504A HUP0300504A HUP0300504A3 HU P0300504 A3 HUP0300504 A3 HU P0300504A3 HU 0300504 A HU0300504 A HU 0300504A HU P0300504 A HUP0300504 A HU P0300504A HU P0300504 A3 HUP0300504 A3 HU P0300504A3
- Authority
- HU
- Hungary
- Prior art keywords
- 17betha
- 16alpha
- 17alpha
- pregna
- trien
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10048634A DE10048634A1 (en) | 2000-09-27 | 2000-09-27 | 19-Nor-17alpha-pregna-1,3,5 (10) -trien-17beta-ole with a 21, 16alpha lactone ring |
PCT/EP2001/011061 WO2002026763A1 (en) | 2000-09-27 | 2001-09-25 | 19-NOR-17α-PREGNA-1,3,5 (10)-TRIEN-17β-OLS OF A 21,16α-LACTONE RING |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0300504A2 HUP0300504A2 (en) | 2003-06-28 |
HUP0300504A3 true HUP0300504A3 (en) | 2003-12-29 |
Family
ID=7658321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300504A HUP0300504A3 (en) | 2000-09-27 | 2001-09-25 | 19-nor-17alpha-pregna-1,3,5(10)-trien-17betha-ols of a 21,16alpha-lactone ring, process for their preparation and pharmaceutical compositions containing them |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1322662A1 (en) |
AU (1) | AU2001293843A1 (en) |
DE (1) | DE10048634A1 (en) |
HU (1) | HUP0300504A3 (en) |
IL (1) | IL151782A0 (en) |
NO (1) | NO20025201L (en) |
WO (1) | WO2002026763A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10214180A1 (en) * | 2002-03-27 | 2003-10-16 | Schering Ag | 11beta-lankgettig-substituted 19-nor-17alpha-pregna-1,3,5 (10) -triene-17beta-ols with a 21,16alpha lactone ring |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3920634A (en) * | 1974-08-30 | 1975-11-18 | Lilly Co Eli | 2,3-Dihydroestra-1,3,5(10)-trieno (16{60 ,17{60 -{62 ) furan-17{62 ols |
DE19906159A1 (en) * | 1999-02-09 | 2000-08-10 | Schering Ag | 16-hydroxyestratrienes as selectively active estrogens |
DE19917930A1 (en) * | 1999-04-15 | 2000-10-19 | Schering Ag | Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity |
DE19954105A1 (en) * | 1999-11-02 | 2001-05-17 | Schering Ag | Treatment of estrogen deficiency-associated conditions, e.g. menopausal syndrome, osteoporosis, infertility or prostatic hypertrophy, using new or known gonatrienes having tissue-selective estrogenic activity |
-
2000
- 2000-09-27 DE DE10048634A patent/DE10048634A1/en not_active Ceased
-
2001
- 2001-09-25 AU AU2001293843A patent/AU2001293843A1/en not_active Abandoned
- 2001-09-25 EP EP01974292A patent/EP1322662A1/en not_active Withdrawn
- 2001-09-25 HU HU0300504A patent/HUP0300504A3/en unknown
- 2001-09-25 WO PCT/EP2001/011061 patent/WO2002026763A1/en not_active Application Discontinuation
- 2001-09-25 IL IL15178201A patent/IL151782A0/en unknown
-
2002
- 2002-10-30 NO NO20025201A patent/NO20025201L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE10048634A1 (en) | 2002-04-18 |
WO2002026763A1 (en) | 2002-04-04 |
IL151782A0 (en) | 2003-04-10 |
NO20025201D0 (en) | 2002-10-30 |
HUP0300504A2 (en) | 2003-06-28 |
NO20025201L (en) | 2002-10-30 |
EP1322662A1 (en) | 2003-07-02 |
AU2001293843A1 (en) | 2002-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0301187A3 (en) | Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0301069A3 (en) | Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0300207A3 (en) | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes | |
PL355844A1 (en) | Novel pharmaceutical compositions of anti-tubrcular drugs and process for their preparation | |
HUP0002843A3 (en) | New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1067626A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
AP2002002575A0 (en) | Compounds having hypolupedemic and hypocholestermic activities process for their preparation and pharmaceutical compositions containing them | |
HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
HUP0204563A3 (en) | Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions | |
HK1039117B (en) | New piperidine-4-sulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
PL359373A1 (en) | New substituted phthalides, a process for their preparation and pharmaceutical compositions containing them | |
HUP0104272A3 (en) | New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them | |
HUP0302515A3 (en) | Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
HUP0301254A3 (en) | Novel compounds, process fo their preparation and pharmaceutical compositions containing them | |
HUP0102631A3 (en) | 1,1- and 1,2-disubstituted cyclopropane derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0203859A3 (en) | Aminomethyl-phenyl-cyclohexanone derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0302905A3 (en) | Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them | |
HK1049159B (en) | New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them | |
IL147069A0 (en) | Novel benzene derivatives, a process for their preparation and pharmaceutical compositions containing them | |
HU0105328D0 (en) | Novel bicyclic amino-pirazinone compounds, a process for their preparation and pharmaceutical compositions containing them | |
HUP0201146A3 (en) | Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a, process for their preparation and pharmaceutical compositions containing them | |
HK1042094B (en) | New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1049000B (en) | New isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them | |
HUP0202305A2 (en) | Novel vitamin d analogues, process for their preparation and pharmaceutical compositions containing them | |
HUP0300504A3 (en) | 19-nor-17alpha-pregna-1,3,5(10)-trien-17betha-ols of a 21,16alpha-lactone ring, process for their preparation and pharmaceutical compositions containing them |